Ready Conversion of Patients with Well-Controlled, Moderate to Severe, Chronic Malignant Tumor–related Pain on Other Opioids to Tapentadol Extended Release

Tapentadol Prolonged Release Versus Strong Opioids for Severe, Chronic Low Back Pain: Results of an Open-Label, Phase 3b Study

(2013) Rafael Gálvez et al.   ADVANCES IN THERAPY

Effectiveness and Tolerability of Tapentadol Prolonged Release Compared With Prior Opioid Therapy for the Management of Severe, Chronic Osteoarthritis Pain

(2013) Ilona Steigerwald et al.   CLINICAL DRUG INVESTIGATION

Opioid switching from and to tapentadol extended release in cancer patients: conversion ratio with other opioids

(2013) Sebastiano Mercadante et al.   CURRENT MEDICAL RESEARCH AND OPINION

Efficacy and safety of oral tapentadol extended release in Japanese and Korean patients with moderate to severe, chronic malignant tumor-related pain

(2013) Keiichiro Imanaka et al.   CURRENT MEDICAL RESEARCH AND OPINION

Clinical Guideline for Pharmacological Management of Cancer Pain: The Japanese Society of Palliative Medicine Recommendations

(2013) T. Yamaguchi et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Adequacy of Opioid Analgesic Consumption at Country, Global, and Regional Levels in 2010, Its Relationship With Development Level, and Changes Compared With 2006

(2013) Béatrice Duthey et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Analgesic Effect of Switching From Oral Opioids to a Once-a-Day Fentanyl Citrate Transdermal Patch in Patients With Lung Cancer

(2012) Osamu Takakuwa et al.   American Journal of Hospice & Palliative Medicine

Tapentadol in cancer pain management: a prospective open-label study

(2012) Sebastiano Mercadante et al.   CURRENT MEDICAL RESEARCH AND OPINION

Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study

(2012) Ilona Steigerwald et al.   CURRENT MEDICAL RESEARCH AND OPINION

Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC

(2012) Augusto Caraceni et al.   LANCET ONCOLOGY

Emerging drugs for cancer-related pain

(2011) Sebastiano Mercadante   SUPPORTIVE CARE IN CANCER

Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain

(2010) Bernd Lange et al.   ADVANCES IN THERAPY

Efficacy and Safety of Tapentadol Extended Release Compared with Oxycodone Controlled Release for the Management of Moderate to Severe Chronic Pain Related to Osteoarthritis of the Knee

(2010) Marc Afilalo et al.   CLINICAL DRUG INVESTIGATION

Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study

(2010) Robert Buynak et al.   EXPERT OPINION ON PHARMACOTHERAPY

Long-term Safety and Tolerability of Tapentadol Extended Release for the Management of Chronic Low Back Pain or Osteoarthritis Pain

(2010) James E. Wild et al.   Pain Practice

Recent advances in the use of opioids for cancer pain

(2010) Droney   Journal of Pain Research

Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: A 10-day, phase III, randomized, double-blind, active- and placebo-controlled study

(2009) Craig Hartrick et al.   CLINICAL THERAPEUTICS

A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain

(2009) Stephen Daniels et al.   CURRENT MEDICAL RESEARCH AND OPINION

Opioid Rotation from Oral Morphine to Oral Oxycodone in Cancer Patients with Intolerable Adverse Effects: An Open-Label Trial

(2008) M. Narabayashi et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY